GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicine™, today announced ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

基因拷贝数变异（ gene CNV ）是种群适应性进化的主要遗传基础之一，但传统检测种群间基因CNV分化方法存在不少难题。二代测序技术虽然成本较低，但其传统检测手段在面对 CNV 时，容易受到 GC 含量偏差、重复序列以及低测序深度的影响，通常需要进行较深的测序，在样本较多情况下无疑增加了成本。而三代测序技术虽然在 CNV 检测的准确度上表现较好，但费用相对较高。

Request To Download Free Sample of This Strategic Report @ Highlighted with 42 tables and 37 figures, this 121-page report Europe Transcriptomics Market 2021-2031 by Component (Instruments, ...

North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalize ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

Partnership aims to democratize access to advanced genomic analysis tools in Australia & New Zealand Basepair's platform represents a brea ...

Twist Bioscience Corporation (NASDAQ:TWST), a synthetic DNA specialist with a market capitalization of $2.8 billion, recently held its Annual Meeting of Stockholders, resulting in significant ...

Robert Chess, a director at Twist Bioscience Corp (NASDAQ:TWST), a $2.8 billion market cap biotechnology company with a Fair overall financial health rating according to InvestingPro, recently sold 2, ...

New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

Next-generation sequencing, proteomics analysis, and circulating tumor DNA demonstrate how precision medicine advances ...